Reunion Neuroscience Inc.
REUN · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $4,407 | $3,441 | $2,241 | $2,892 |
| G&A Expenses | $3,955 | $3,132 | $3,731 | $2,141 |
| SG&A Expenses | $3,955 | $3,132 | $3,731 | $2,141 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1,508 | $3,531 | $0 | $0 |
| Operating Expenses | $6,854 | $10,104 | $5,972 | $5,033 |
| Operating Income | -$6,756 | -$9,713 | $2,541 | -$4,829 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $263 | -$2,741 | -$16,477 | -$390 |
| Pre-Tax Income | -$6,492 | -$12,455 | -$13,936 | -$5,219 |
| Tax Expense | -$263 | $233 | $9,954 | $18 |
| Net Income | -$6,229 | -$12,688 | -$23,890 | -$5,237 |
| % Margin | – | – | – | – |
| EPS | -0.54 | -1.09 | -2.05 | -0.45 |
| % Growth | 50.5% | 46.8% | -355.6% | – |
| EPS Diluted | -0.54 | -1.09 | -2.05 | -0.45 |
| Weighted Avg Shares Out | 11,639 | 11,645 | 11,641 | 11,630 |
| Weighted Avg Shares Out Dil | 11,639 | 11,645 | 11,641 | 11,630 |
| Supplemental Information | – | – | – | – |
| Interest Income | $277 | $233 | $165 | $18 |
| Interest Expense | -$263 | $233 | $165 | $18 |
| Depreciation & Amortization | -$1,508 | $3,531 | -$9,954 | $1,205 |
| EBITDA | -$8,264 | -$8,691 | -$7,413 | -$3,997 |
| % Margin | – | – | – | – |